Css LLC Curis Inc Call Options Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $74 - $1,501	-100 Reduced 3.33%	2,900 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $71 - $243	100 Added 3.45%	3,000 $3,000
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $74,844 - $166,212	-32,400 Reduced 91.78%	2,900 $7,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $76,735 - $167,581	10,300 Added 41.2%	35,300 $285,000
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $219,499 - $320,000	25,000 New	25,000 $283,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.